Marker Therapeutics (MRKR) Operating Margin (QoQ) (2022 - 2025)
Marker Therapeutics (MRKR) Operating Margin (QoQ) (2022 - 2025) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.54 Bn | 130.69 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.89 Bn | 77.89 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.84 Bn | 59.65 Bn | 1.37 Bn |
| 4 | Moderna | 56.53 Bn | 51.39 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.97 Bn | 36.87 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.53 Bn | 28.22 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.70 Bn | 9.31 Bn | 668.28 Mn |
| 8 | Insmed | 27.45 Bn | 26.29 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - |
| 10 | Marker Therapeutics | 26.70 Mn | 14.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 257.00 |
| Sep 30, 2025 | 32,148.00 |
| Jun 30, 2025 | 92,536.00 |
| Mar 31, 2025 | -124,866.00 |
| Dec 31, 2024 | -4,688.00 |
| Sep 30, 2024 | -920.00 |
| Jun 30, 2024 | 8,949.00 |
| Sep 30, 2023 | -206,410.00 |
| Jun 30, 2023 | 99,425.00 |
| Mar 31, 2023 | 22,790.00 |
| Dec 31, 2022 | 18,262.00 |
| Sep 30, 2022 | 8,358.00 |
| Jun 30, 2022 | 34,924.00 |